Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Other financing activities (2019 - 2021)

Historic Other financing activities for Alaunos Therapeutics (TCRT) over the last 3 years, with Q4 2021 value amounting to $185000.0.

  • Alaunos Therapeutics' Other financing activities changed N/A to $185000.0 in Q4 2021 from the same period last year, while for Dec 2022 it was $183000.0, marking a year-over-year decrease of 9999.85%. This contributed to the annual value of $260000.0 for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q4 2021, Alaunos Therapeutics' Other financing activities is $185000.0.
  • Over the past 5 years, Alaunos Therapeutics' Other financing activities peaked at $185000.0 during Q4 2021, and registered a low of -$2000.0 during Q1 2019.